Literature DB >> 17326768

Degradation of nicastrin involves both proteasome and lysosome.

Guiqiong He1, Hong Qing, Yigang Tong, Fang Cai, Shoichi Ishiura, Weihong Song.   

Abstract

The glycoprotein nicastrin (NCT) is an essential component of the gamma-secretase complex, a high molecular weight complex which also contains the presenilin proteins, Aph-1 and Pen-2. The gamma-secretase complex is not only involved in APP processing but also in the processing of an increasing number of other type I integral membrane proteins. As the largest subunit of the gamma-secretase complex, NCT plays a crucial role in its activation. Considerable information exists on the distribution, structure and function of NCT; however, little is known of its proteolysis. The present study is aimed at exploring the molecular mechanism of NCT degradation. We found that either proteasomal or lysosomal inhibition can significantly increase the levels of both endogenous and exogenous NCT in various cell lines, and the effect of these inhibitions on NCT was time- and dose-dependent. Immunofluorescent microscopic analysis revealed that NCT accumulates in the ER and Golgi apparatus after proteasomal inhibition, while lysosomal inhibition leads to the accumulation of NCT in the lysosomal apparatus. Co-immunoprecipitation can pull down both NCT and ubiquitin. Taken together, our results demonstrate that NCT degradation involves both the proteasome and the lysosome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17326768     DOI: 10.1111/j.1471-4159.2007.04449.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.

Authors:  Mahua Maulik; Kyle Peake; JiYun Chung; Yanlin Wang; Jean E Vance; Satyabrata Kar
Journal:  Hum Mol Genet       Date:  2015-10-03       Impact factor: 6.150

Review 2.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Degradation of gamma secretase activating protein by the ubiquitin-proteasome pathway.

Authors:  Jin Chu; Jian-Guo Li; Nicholas E Hoffman; Muniswamy Madesh; Domenico Praticò
Journal:  J Neurochem       Date:  2015-02-13       Impact factor: 5.372

Review 4.  The multiple mechanisms of amyloid deposition: the role of parkin.

Authors:  Maria A Mena; José A Rodríguez-Navarro; Justo García de Yébenes
Journal:  Prion       Date:  2009-01-09       Impact factor: 3.931

5.  Endolysosome involvement in LDL cholesterol-induced Alzheimer's disease-like pathology in primary cultured neurons.

Authors:  Liang Hui; Xuesong Chen; Jonathan D Geiger
Journal:  Life Sci       Date:  2012-05-11       Impact factor: 5.037

Review 6.  Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways.

Authors:  Mohamed A Eldeeb; Mohamed A Ragheb; Marwa H Soliman; Richard P Fahlman
Journal:  Neurotox Res       Date:  2022-01-18       Impact factor: 3.911

7.  Phosphorylation of nicastrin by SGK1 leads to its degradation through lysosomal and proteasomal pathways.

Authors:  Jung-Soon Mo; Ji-Hye Yoon; Ji-Ae Hong; Mi-Yeon Kim; Eun-Jung Ann; Ji-Seon Ahn; Su-Man Kim; Hyeong-Jin Baek; Florian Lang; Eui-Ju Choi; Hee-Sae Park
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

8.  Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo.

Authors:  Mingming Zhang; Fang Cai; Shuting Zhang; Si Zhang; Weihong Song
Journal:  Sci Rep       Date:  2014-12-03       Impact factor: 4.379

Review 9.  The very many faces of presenilins and the γ-secretase complex.

Authors:  Michalina Smolarkiewicz; Tomasz Skrzypczak; Przemysław Wojtaszek
Journal:  Protoplasma       Date:  2013-03-16       Impact factor: 3.356

10.  Cyclic RNA hsa‑circ‑000595 regulates apoptosis of aortic smooth muscle cells.

Authors:  Chengfei Zheng; Hui Niu; Ming Li; Hongkun Zhang; Zhenggang Yang; Lu Tian; Ziheng Wu; Donglin Li; Xudong Chen
Journal:  Mol Med Rep       Date:  2015-08-28       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.